Beckman Life Sciences Flow Cytometer Recall Gets Class I FDA Designation

Nov 21, 2018

|

NEW YORK (360Dx) — Beckman Coulter Life Sciences said on Tuesday that its voluntary recall of its FC500 and EPIC flow cytometry instruments earlier this year has been classified as Class 1 by the US Food and Drug Administration.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Beckman Life Sciences Flow Cytometer Recall Gets Class I FDA Designation

To read the full story....

Breaking News

Zymo Research Gets CE-IVD Mark for Sample Collection Devices

Angle Files De Novo FDA Submission for CTC Collection Device in Breast Cancer

LabCorp, Genfit Partner to Commercialize Liver Disease Diagnostic Test

Hologic Receives FDA Emergency Use Authorization for SARS-CoV-2 Testing of Asymptomatic Individuals

Quotient Limited Gets FDA Emergency Use Authorization for Coronavirus Antibody Test

Palmetto Expands Coverage for Decipher Biosciences Prostate Cancer Test

Featured White Papers

The Promise of Liquid Biopsy for Cancer Diagnostics and Therapeutic Monitoring: Are We There Yet?

Sponsorships